Regeneron Pharmaceuticals (REGN) Prepaid Assets (2009 - 2026)

Regeneron Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $620.9 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 32.42% year-over-year to $620.9 million in Q1 2026; TTM through Mar 2026 was $620.9 million, a 32.42% increase from a year earlier, with the FY2025 full-year figure at $474.8 million, up 35.97% from the prior year.
• Prepaid Assets advanced to $620.9 million in Q1 2026 per REGN's latest filing, from $474.8 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $681.9 million in Q2 2024 and bottomed at $349.2 million in Q4 2024.
• The 5-year median for Prepaid Assets is $446.4 million (2022), against an average of $481.9 million.
• Across the five-year window, Prepaid Assets surged 98.92% in 2022 and sank 37.23% in 2023, its largest moves.
• Year by year, Prepaid Assets stood at $411.2 million in 2022, then decreased by 5.98% to $386.6 million in 2023, then slipped by 9.67% to $349.2 million in 2024, then surged by 35.97% to $474.8 million in 2025, then jumped by 30.77% to $620.9 million in 2026.
• Per Business Quant, the three latest REGN Prepaid Assets figures stand at $620.9 million (Q1 2026), $474.8 million (Q4 2025), and $595.6 million (Q3 2025).